IHRA, developed by Aarca Research, revolutionizes early detection of metabolic conditions such as Type 2 Diabetes, Hypertension, and Dyslipidemia. Using proprietary software and a third-party thermal camera, IHRA provides risk scores that are crucial for early intervention and management."

Key Features:

Non-Invasive Technology: Safe and non-invasive metabolic health risk assessment using thermal imaging.
Rapid Results: Delivers risk scores in real-time, aiding swift decision-making.
Comprehensive Risk Analysis: Assesses multiple conditions simultaneously to provide a holistic view of metabolic health.

Sample report:

Technical Specifications:

Technology: Utilises medical thermal imaging with advanced data analytics.
Compatibility: Leverages proprietary software and integrates seamlessly into diverse health systems.
Output: Provides detailed reports outlining individual risk scores for targeted conditions.

User Benefits:

Early Detection: Empowers physicians with the information needed to prevent the progression of metabolic diseases.
Patient Convenience: Simplifies the health assessment process, requiring minimal patient preparation and no physical discomfort.
Enhanced Healthcare Delivery: Enables more effective population health management through scalable screenings.

On-site health screening steps

Hover over or click the cards to see the steps in detail.

Step 1

(2 mins)

Patient is at the screening location.
Patient will be asked to sit for 10 minutes if he is sweating, to bring her body temperature to room temperature.

Step 2

(2 mins)

Step 2

(2 mins)

Patient completes a web-based questionier with details of their medical and family history and lifestyle information.

Step 3

(1 min)

Step 3

(1 min)

Using an FDA Cleared thermal camera, a one-minute thermal video of the patient's face is taken.
The thermal video is upload to cloud software.

Step 4

(2 mins)

Step 4

(2 mins)

Our proprietary software analyses this thermal video and a report will be generated. It will be emailed to the patient.
If requested, the report will also be made available to a medical professional with the patient consent.

Clinical Validation:

IHRA has undergone extensive clinical trials, proving its efficacy and accuracy in early risk assessment. It's recognized by healthcare professionals for its innovative approach to preventive health. Clinical Trials link in research

Customer Testimonials:

"NerveVue has changed how we manage our PAD patients—faster, safer, and more reliable," says Dr. Jagadish Arora, a vascular specialist.
"The ease of use and quick results make NerveVue indispensable in our practice," shares Nurse Satya Srinivas.

IHRA Applications Across Various Settings:

Hospitals: Enhances routine screenings and patient monitoring with non-invasive, rapid health risk assessments.
Insurance Companies: Provides accurate health risk data for underwriting and policy customization.
Corporates: Integrates into employee wellness programs to monitor and manage health risks proactively.
Public Health: Enables large-scale screenings to identify and mitigate prevalent health risks in communities.

IHRA

Key Features:

Sample report:

Technical Specifications:

User Benefits:

Step 1

Step 1

(2 mins)

Step 2

(2 mins)

Step 2

(2 mins)

Step 3

(1 min)

Step 3

(1 min)

Step 4

(2 mins)

Step 4

(2 mins)

Clinical Validation:

Customer Testimonials:

"NerveVue has changed how we manage our PAD patients—faster, safer, and more reliable," says Dr. Jagadish Arora, a vascular specialist.
"The ease of use and quick results make NerveVue indispensable in our practice," shares Nurse Satya Srinivas.

IHRA Applications Across Various Settings:

FAQs:

Save time, reduce cost, and improve outcomes by
detecting Type 2 Diabetes, Hypertension and Dyslipidemia Early.

Quick Menu

Request a Demo

IHRA

Key Features:

Sample report:

Technical Specifications:

User Benefits:

Step 1

Step 1

(2 mins)

Step 2

(2 mins)

Step 2

(2 mins)

Step 3

(1 min)

Step 3

(1 min)

Step 4

(2 mins)

Step 4

(2 mins)

Clinical Validation:

Customer Testimonials:

"NerveVue has changed how we manage our PAD patients—faster, safer, and more reliable," says Dr. Jagadish Arora, a vascular specialist."The ease of use and quick results make NerveVue indispensable in our practice," shares Nurse Satya Srinivas.

IHRA Applications Across Various Settings:

FAQs:

Save time, reduce cost, and improve outcomes by detecting Type 2 Diabetes, Hypertension and Dyslipidemia Early.

Quick Menu

"NerveVue has changed how we manage our PAD patients—faster, safer, and more reliable," says Dr. Jagadish Arora, a vascular specialist.
"The ease of use and quick results make NerveVue indispensable in our practice," shares Nurse Satya Srinivas.

Save time, reduce cost, and improve outcomes by
detecting Type 2 Diabetes, Hypertension and Dyslipidemia Early.